Be Careful Using Gliptins in Heart Failure Patients
So far, saxagliptin has the strongest evidence. There's one heart failure hospitalization for every 143 patients treated with saxagliptin over 2 years.
Alogliptin seems less likely to be linked to heart failure...sitagliptin (Januvia) doesn't seem to be a problem...and it's too early to say if linagliptin (Tradjenta) increases risk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote